Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mechanism of Eravacycline Resistance in Clinical Enterococcus faecalis Isolates From China

25 May 2020

Abstract excerpt

Opportunistic infections caused by multidrug resistant Enterococcus faecalis strains are a significant clinical challenge. Eravacycline (Erava) is a synthetic fluorocycline structurally similar to tigecycline (Tige) that exhibits robust antimicrobial activity against Gram-positive bacteria. This study investigated the in vitro antimicrobial activity and heteroresistance risk of Eravacycline (Erava) in clinical E....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial Resistance in Staphylococcus
Share to Bacterial Identification and Susceptibility Testing
Share to Infective Endocarditis Diagnosis and Management

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32523563
DOI: 10.3389/fmicb.2020.00916

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mechanism of Eravacycline Resistance in Clinical Enterococcus faecalis Isolates From ChinaPMID 32523563Read ↗

Eravacycline activity against clinical S. aureus isolates from China: in vitro activity, MLST profiles and heteroresistanceSemantic proximity Read ↗

Eravacycline susceptibility was impacted by genetic mutation of 30S ribosome subunits, and branched-chain amino acid transport system II carrier protein, Na/Pi cotransporter family protein in Staphylococcus aureus.Semantic proximity Read ↗

Eravacycline susceptibility was impacted by genetic mutation of 30S ribosome subunits, and branched-chain amino acid transport system II carrier protein, Na/Pi cotransporter family protein in Staphylococcus aureusSemantic proximity Read ↗

Omadacycline Efficacy against Enterococcus faecalis Isolated in China: In Vitro Activity, Heteroresistance, and Resistance Mechanisms.Semantic proximity Read ↗

Comparison of antimicrobial efficacy of eravacycline and tigecycline against clinical isolates of Streptococcus agalactiae in China: In vitro activity, heteroresistance, and cross-resistanceSemantic proximity Read ↗

Comparison of antimicrobial activities and resistance mechanisms of eravacycline and tigecycline against clinical Acinetobacter baumannii isolates in ChinaSemantic proximity Read ↗

In vitro antimicrobial activity and resistance mechanisms of the new generation tetracycline agents, eravacycline, omadacycline, and tigecycline against clinical Staphylococcus aureus isolatesSemantic proximity Read ↗

The Y58D mutation in rpsJ gene is correlated with tigecycline and eravacycline combined resistance in ST80 vancomycin-resistant Enterococcus faecium isolates.Semantic proximity Read ↗

Development of Resistance to Eravacycline by Klebsiella pneumoniae and Collateral Sensitivity-Guided Design of Combination TherapiesSemantic proximity Read ↗

Occurrence and mechanisms of tigecycline resistance in carbapenem- and colistin-resistant Klebsiella pneumoniae in ThailandSemantic proximity Read ↗

Genomic epidemiology reveals multiple mechanisms of linezolid resistance in clinical enterococci in ChinaSemantic proximity Read ↗

Genetic diversity and characteristics of high-level tigecycline resistance Tet(X) in Acinetobacter species.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.